Differential effects of Gram-positive versus Gram-negative bacteria on NOSII and TNFα in macrophages: Role of TLRs in synergy between the two

British Journal of Pharmacology

Volumn 148, Issue 8, 2006, Pages 1067-1075

  Paul Clark, Mark J ^a   Mc Master, Shaun K ^a   Belcher, Elizabeth ^a   Sorrentino, Rosalinda ^a   Anandarajah, Jasmine ^a   Fleet, Mark ^a   Sriskandan, Shiranee ^b   Mitchell, Jane A ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Bacteria; LPS; Nitric oxide; PAMPs; Purrs; TNF; Toll like receptors

Indexed keywords

ADAPTOR PROTEIN; ANTIBODY; CYSTEINE DERIVATIVE; FIBROBLAST STIMULATING LIPOPEPTIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIGAND; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; LYSINE DERIVATIVE; MYELOID DIFFERENTIATION FACTOR 88; N PALMITOYL S [2,3 BIS(PALMITOYLOXY)PROPYL]CYSTEINYLSERYLLYSYLLYSYLLYSYLLYSINE; NITRIC OXIDE; PROTEIN TRIF; SERINE DERIVATIVE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; ESCHERICHIA COLI; GENE INDUCTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RECEPTOR UPREGULATION; STAPHYLOCOCCUS AUREUS;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; DNA PRIMERS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NITRIC OXIDE SYNTHASE TYPE II; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33747104542     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706815     Document Type: Article

References (24)

1. ANANDARAJAH, J., FLEET, M.R., WALTERS, M.J., BELCHER, P.E., SRISKANDAN, S. & MITCHELL, J.A. (2003). Gram positive and Gram negative bacteria synergise to cause nitric oxide synthase induction in murine macrophages. Br. J. Pharmcol., 140, 5P.
2. BELCHER, P.E., EVANS, T.W., SRISKANDAN, S. & MITCHELL, J.A. (2003). Gram-positive Staphylococcus aureus contrasts with Gram-negative Escherichia coli in the induction of tumour factor-alpha and nitric oxide from macrophages. Br. J. Anaesthesia, 90, 540P-541P.
3. BEUTLER, E., GELBART, T. & WEST, C. (2001). Synergy between TLR2 and TLR4: a safety mechanism. Blood Cells Mol. Dis., 27, 728-730.
4. BISHOP-BAILEY, D., LARKIN, S.W., WARNER, T.D., CHEN, G. & MITCHELL, J.A. (1997). Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. Br. J. Pharmacol., 21, 125-133.
5. BRUN-BUISSON, C., DOYON, F. & CARLET, J. (1996). Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am. J. Respir. Crit. Care Med., 154, 617.
6. CARTWRIGHT, N., SRISKANDAN, S., QUESNIAUX, V., RYFFEL, B., EVANS, T.W. & MITCHELL, J.A. (2005). Role of TLR2 and TLR6 in vascular dysfunction induced by Gram positive bacteria. Br. J. Pharmacol. (pA2 online), 3, 152P.
7. FISCHER, W. & ROSEL, P. (1980). The alanine ester substitution of lipoteichoic acid (LTA) in Staphylococcus aureus. FEBS Lett., 119, 224-226.
8. GAO, J.J., Q. XUE, E.G., ZUVANICH, K.R., HAGH, I. & MORRISON, D.C. (2001). Commercial preparations of lipoteichoic acid contain endotoxin that contributes to activation of mouse macrophages in vitro. Infect. Immun., 69, 751-757.
9. JIMENEZ, R., BELCHER, E., SRISKANDAN, S., LUCAS, R., MCMASTER, S., VOJNOVIC, I., WARNER, T.D. & MITCHELL, J.A. (2005). Role of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle. Proc. Natl. Acad. Sci. U.S.A., 102, 4637-4642.
10. JONES, B.W., HELDWEIN, K.A., MEANS, T.K., SAUKKONEN, J.J. & FENTON, M.J. (2001). Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages. Ann. Rheum. Dis., 60 (Suppl 3), iii6-iii12.
11. KENGATHARAN, M., DE KIMPE, S.J. & THIEMERMANN, C. (1996). Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages. Br. J. Pharmacol., 117, 1163-1172.
12. MATSUGUCHI, T., MUSIKACHAROEN, T., OGAWA, T. & YOSHIKAI, Y. (2000). Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J. Immunol., 165, 5767-5772.
13. MOLLER, A.S., OVSTEBO, R., HAUG, K.B., JOO, G.B., WESTVIK, A.B. & KIERULF, P. (2005). Chemokine production and pattern recognition receptor (PRR) expression in whole blood stimulated with pathogen-associated molecular patterns (PAMPs). Cytokine, 32, 304-315.
14. MORATH, S., GEYER, A., SPREITZER, I., HERMANN, C. & HARTUNG, T. (2002). Structural decomposition and heterogeneity of commercial lipoteichoic acid preparations. Infect. Immun., 70, 938-942.
15. MOYNAGH, P.N. (2005). TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol., 26, 469-476.
16. SATO, S., NOMURA, F., KAWAI, T., TAKEUCHI, O., MUHLRADT, P.F., TAKEDA, K. & AKIRA, S. (2000). Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J. Immunol., 165, 7096-7101.
17. TAKEUCHI, O., HOSHINO, T., KAWAI, H., SANJO, H., TAKADA, T., OGAWA, K., TAKEDA, K. & AKIRA, S. (1999). Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity, 11, 443-451.
18. TOSHCHAKOV, V., JONES, B.W., PERERA, P.Y., THOMAS, K., CODY, M.J., ZHANG, S., WILLIAMS, B.R., MAJOR, J., HAMILTON, T.A., FENTON, M.J. & VOGEL, S.N. (2002). TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat. Immunol., 3, 392-398.
19. TRAVASSOS, L.H., GIRARDIN, S.E., PHILPOTT, D.J., BLANOT, D., NAHORI, M.A., WERTS, C. & BONECA, I.G. (2004). Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep., 5, 1000-1006.
20. VAN HEEL, D.A., GHOSH, S., BUTLER, M., HUNT, K., FOXWELL, B.M., MENGIN-LECREULX, D. & PLAYFORD, R.J. (2005). Synergistic enhancement of Toll-like receptor responses by NOD1 activation. Eur. J. Immunol., 35, 2471-2476.
21. VOGEL, S.N., FITZGERALD, K.A. & FENTON, M.J. (2003). TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol. Interv., 3, 466-477.
22. WANG, J.E., JORGENSEN, P.F, ELLINGSEN, E.A., ALMIOF, M., THIEMERMANN, C., FOSTER, S.J., AASEN, A.O. & SOLBERG, R. (2001). Peptidoglycan primes for LPS-induced release of proinflammatory cytokines in whole human blood. Shock, 16, 178-182.
23. WEINSTEIN, M.P., MURPHY, J.R., RELLER, L.B. & LICHTENSTEIN, K.A. (1983). The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev. Infect. Dis., 5, 54-70.
24. WEST, M.A., BENNET, T. & CLAIR, L. (1995). Reprogrammed macrophage tumor necrosis factor and interleukin-1 release with inflammatory pretreatment: differential regulation by endotoxin and zymosan. J. Trauma, 39, 404-410.